A phase 1 study to assess potential interaction between ASP8062 and alcohol in healthy adult subjects

Addolorato, G, Leggio, L (2010) Safety and efficacy of baclofen in the treatment of alcohol-dependent patients. Current Pharmaceutical Design 16(19): 2113–2117.
Google Scholar | Crossref | Medline Agabio, R, Maccioni, P, Carai, MA, et al. (2012) The development of medications for alcohol-use disorders targeting the GABAB receptor system. Recent Patents on CNS Drug Discovery 7(2): 113–128.
Google Scholar | Crossref | Medline Agabio, R, Sinclair, JM, Addolorato, G, et al. (2018) Baclofen for the treatment of alcohol use disorder: The Cagliari Statement. Lancet Psychiatry 5(12): 957–960.
Google Scholar | Crossref | Medline Augier, E (2021) Recent advances in the potential of positive allosteric modulators of the GABAB receptor to treat alcohol use disorder. Alcohol and Alcoholism 56(2): 139–148.
Google Scholar | Crossref | Medline Augier, E, Dulman, RS, Damadzic, R, et al. (2017) The GABAB positive allosteric modulator ADX71441 attenuates alcohol self-administration and relapse to alcohol seeking in rats. Neuropsychopharmacology 42(9): 1789–1799.
Google Scholar | Crossref | Medline Chen, X, Jacobs, G, de Kam, ML, et al. (2015) AZD6280, a novel partial gamma-aminobutyric acid A receptor modulator, demonstrates a pharmacodynamically selective effect profile in healthy male volunteers. Journal of Clinical Psychopharmacology 35(1): 22–33.
Google Scholar | Crossref | Medline Evans, SM, Bisaga, A (2009) Acute interaction of baclofen in combination with alcohol in heavy social drinkers. Alcoholism: Clinical and Experimental Research 33(1): 19–30.
Google Scholar | Crossref | Medline Evenseth, LSM, Gabrielsen, M, Sylte, I (2020) The GABA(B) receptor-structure, ligand binding and drug development. Molecules 25: 3093.
Google Scholar | Crossref Farokhnia, M, Deschaine, SL, Sadighi, A, et al. (2021) A deeper insight into how GABA-B receptor agonism via baclofen may affect alcohol seeking and consumption: Lessons learned from a human laboratory investigation. Molecular Psychiatry 26(2): 545–555.
Google Scholar | Crossref | Medline Farokhnia, M, Schwandt, ML, Lee, MR, et al. (2017) Biobehavioral effects of baclofen in anxious alcohol-dependent individuals: A randomized, double-blind, placebo-controlled, laboratory study. Translational Psychiatry 7(4): e1108.
Google Scholar | Crossref | Medline Foerster, BR, Petrou, M, Edden, RA, et al. (2012) Reduced insular γ-aminobutyric acid in fibromyalgia. Arthritis & Rheumatism 64(2): 579–583.
Google Scholar | Crossref | Medline Haile, CN, Carper, BA, Nolen, TL, et al. (2021) The GABAB receptor positive allosteric modulator ASP8062 reduces operant alcohol self-administration in male and female Sprague Dawley rats. Psychopharmacology 239: 2587–2600.
Google Scholar | Crossref Holajova, M, Franek, M (2018) Effect of short- and long-term administration of baclofen on spatial learning and memory in rats. Physiological Research 67(1): 133–141.
Google Scholar | Crossref | Medline Katz, DA, Locke, C, Liu, W, et al. (2016) Single-dose interaction study of the arginine vasopressin type 1B receptor antagonist ABT-436 and alcohol in moderate alcohol drinkers. Alcoholism, Clinical and Experimental Research 40(4): 838–845.
Google Scholar | Crossref | Medline Leggio, L, Zywiak, WH, McGeary, JE, et al. (2013) A human laboratory pilot study with baclofen in alcoholic individuals. Pharmacology Biochemistry and Behavior 103(4): 784–791.
Google Scholar | Crossref | Medline Lowe, SL, Wong, CJ, Witcher, J, et al. (2014) Safety, tolerability, and pharmacokinetic evaluation of single- and multiple-ascending doses of a novel kappa opioid receptor antagonist LY2456302 and drug interaction with ethanol in healthy subjects. Journal of Clinical Pharmacology 54(9): 968–978.
Google Scholar | Crossref | Medline Maccioni, P, Colombo, G (2019) Potential of GABA(B) receptor positive allosteric modulators in the treatment of alcohol use disorder. CNS Drugs 33(2): 107–123.
Google Scholar | Crossref | Medline Maccioni, P, Fara, F, Lorrai, I, et al. (2019) Suppressing effect of CMPPE, a new positive allosteric modulator of the GABAB receptor, on alcohol self-administration and reinstatement of alcohol seeking in rats. Alcohol 75: 79–87.
Google Scholar | Crossref | Medline McIntosh, C, Chick, J (2004) Alcohol and the nervous system. Journal of Neurology, Neurosurgery, and Psychiatry 75(Suppl. 3): iii16–iii21.
Google Scholar | Crossref | Medline May, LT, Avlani, VA, Sexton, PM, et al. (2004) Allosteric modulation of G protein-coupled receptors. Current Pharmaceutical Design 10(17): 2003–2013.
Google Scholar | Crossref | Medline Morrison, RL, Fedgchin, M, Singh, J, et al. (2018) Effect of intranasal esketamine on cognitive functioning in healthy participants: A randomized, double-blind, placebo-controlled study. Psychopharmacology 235(4): 1107–1119.
Google Scholar | Crossref | Medline Murai, N, Kondo, Y, Akuzawa, S, et al. (2019) A novel GABA(B) receptor positive allosteric modulator, ASP8062, exerts analgesic effects in a rat model of fibromyalgia. European Journal of Pharmacology 865: 172750.
Google Scholar | Crossref | Medline Olsen, R (2002) GABA. In: Davis, KL, Charney, D, Coyle, J, et al. (eds) Neuropsychopharmacology: The Fifth Generation of Progress. Philadelphia, PA: American College of Neuropsychopharmacology and Lippincott, Williams, & Wilkins, pp.159–167.
Google Scholar Pierce, M, Sutterland, A, Beraha, EM, et al. (2018) Efficacy, tolerability, and safety of low-dose and high-dose baclofen in the treatment of alcohol dependence: A systematic review and meta-analysis. European Neuropsychopharmacology 28(7): 795–806.
Google Scholar | Crossref | Medline Pin, JP, Prezeau, L (2007) Allosteric modulators of GABA(B) receptors: Mechanism of action and therapeutic perspective. Current Neuropharmacology 5(3): 195–201.
Google Scholar | Crossref | Medline | ISI Thai, D, Dyer, JE, Benowitz, NL, et al. (2006) Gamma-hydroxybutyrate and ethanol effects and interactions in humans. Journal of Clinical Psychopharmacology 26(5): 524–529.
Google Scholar | Crossref | Medline Varani, AP, Aso, E, Moutinho, LM, et al. (2014) Attenuation by baclofen of nicotine rewarding properties and nicotine withdrawal manifestations. Psychopharmacology 231(15): 3031–3040.
Google Scholar | Crossref | Medline Vengeliene, V, Takahashi, TT, Dravolina, OA, et al. (2018) Efficacy and side effects of baclofen and the novel GABA(B) receptor positive allosteric modulator CMPPE in animal models for alcohol and cocaine addiction. Psychopharmacology 235(7): 1955–1965.
Google Scholar | Crossref | Medline Walzer, M, Marek, GJ, Wu, R, et al. (2020) Single- and multiple-dose safety, tolerability, and pharmacokinetic profiles of ASP8062: Results from 2 phase 1 studies. Clinical Pharmacology in Drug Development 9(3): 297–306.
Google Scholar | Crossref | Medline Walzer, M, Wu, R, Ahmad, M, et al. (2021) A randomized phase 1 single-dose polysomnography study of ASP8062, a GABAB receptor positive allosteric modulator. Psychopharmacology 238: 867–876.
Google Scholar | Crossref | Medline

留言 (0)

沒有登入
gif